Business Segments · Net Interest Expense

Business Segments — Net Interest Expense

Amgen Business Segments — Net Interest Expense decreased by 4.1% to $657.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.1%, from $723.00M to $657.00M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ1 2024
Last reportedQ1 2026

How to read this metric

Lower net interest expense indicates a healthier balance sheet and lower financial risk.

Detailed definition

The net cost of servicing the company's debt obligations after accounting for any interest income. This metric is a key...

Peer comparison

Standard 'Net Interest Expense' across all capital-intensive industries.

Metric ID: amgn_segment_reportable_segment_interest_expense_net

Historical Data

7 periods
 Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$824.00M$808.00M$776.00M$723.00M$694.00M$685.00M$657.00M
QoQ Change-1.9%-4.0%-6.8%-4.0%-1.3%-4.1%
YoY Change-12.3%-14.1%-11.7%-9.1%
Range$657.00M$824.00M
CAGR-14.0%
Avg YoY Growth-11.8%
Median YoY Growth-12.0%
Current Streak6+ quarters decline

Frequently Asked Questions

What is Amgen's business segments — net interest expense?
Amgen (AMGN) reported business segments — net interest expense of $657.00M in Q1 2026.
How has Amgen's business segments — net interest expense changed year-over-year?
Amgen's business segments — net interest expense decreased by 9.1% year-over-year, from $723.00M to $657.00M.
What does business segments — net interest expense mean?
The net cost of interest paid on the company's debt after subtracting interest earned.